UK (Parliament Politic Magazine) – Oxford Cannabinoid Technologies Plc (OCTP), a company dedicated to the development of cannabinoid-based medicines since 2017, made an exciting announcement this week. They are expanding their research and development efforts to focus on a groundbreaking new drug